Avecho Biotechnology Limited (FRA:OEZ)
Germany
· Delayed Price · Currency is EUR 0.0040
-0.0010 (-20.00%)
At close: Dec 5, 2025
Avecho Biotechnology Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -3.62 | -3.12 | -3.44 | -2.34 | -3.42 | -2.63 | Upgrade
|
| Depreciation & Amortization | 0.14 | 0.14 | 0.18 | 0.23 | 0.43 | 0.54 | Upgrade
|
| Stock-Based Compensation | 0.01 | 0.01 | 0.1 | 0.2 | 0.53 | 0.53 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0 | -0.02 | 0.05 | - | Upgrade
|
| Other Operating Activities | 5.71 | 0.05 | 0.37 | - | - | -0.18 | Upgrade
|
| Change in Accounts Receivable | -1.15 | -1.15 | -0.35 | 0.4 | -0.67 | 0.28 | Upgrade
|
| Change in Inventory | -0.04 | -0.04 | -0.06 | -0.21 | -0.1 | 0.05 | Upgrade
|
| Change in Accounts Payable | 0.03 | 0.03 | -0.09 | 0.03 | 0.03 | 0.05 | Upgrade
|
| Change in Unearned Revenue | -0.16 | -0.16 | 0.16 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.26 | 0.26 | -0.04 | 0.04 | 0.04 | -0.05 | Upgrade
|
| Operating Cash Flow | 1.19 | -3.97 | -3.18 | -1.67 | -3.1 | -1.42 | Upgrade
|
| Capital Expenditures | - | - | - | -0.05 | -0.2 | -0.01 | Upgrade
|
| Other Investing Activities | -0.02 | -0.02 | - | - | - | 0 | Upgrade
|
| Investing Cash Flow | -0.02 | -0.02 | - | -0.05 | -0.2 | -0 | Upgrade
|
| Short-Term Debt Issued | - | 0.93 | - | - | - | - | Upgrade
|
| Total Debt Issued | 0.93 | 0.93 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.08 | -0.07 | -0.08 | -0.07 | -0.08 | Upgrade
|
| Net Debt Issued (Repaid) | -0.08 | 0.85 | -0.07 | -0.08 | -0.07 | -0.08 | Upgrade
|
| Issuance of Common Stock | - | - | 8 | 0 | 5.06 | - | Upgrade
|
| Other Financing Activities | - | - | -0.72 | - | -0.29 | - | Upgrade
|
| Financing Cash Flow | -0.08 | 0.85 | 7.22 | -0.08 | 4.69 | -0.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | 0.17 | Upgrade
|
| Net Cash Flow | 1.1 | -3.13 | 4.04 | -1.8 | 1.39 | -1.34 | Upgrade
|
| Free Cash Flow | 1.19 | -3.97 | -3.18 | -1.72 | -3.3 | -1.43 | Upgrade
|
| Free Cash Flow Margin | 86.31% | -350.38% | -671.51% | -152.16% | -416.01% | -371.56% | Upgrade
|
| Free Cash Flow Per Share | - | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | Upgrade
|
| Cash Interest Paid | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.01 | Upgrade
|
| Cash Income Tax Paid | - | -1.07 | -0.72 | -1.04 | - | - | Upgrade
|
| Levered Free Cash Flow | -2.28 | -2.85 | -1.89 | -0.86 | -1.99 | -0.38 | Upgrade
|
| Unlevered Free Cash Flow | -2.21 | -2.81 | -1.88 | -0.86 | -1.99 | -0.37 | Upgrade
|
| Change in Working Capital | -1.05 | -1.05 | -0.39 | 0.27 | -0.69 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.